Skip to main content
C

CELLUMED CO., LTD. — Investor Relations & Filings

Ticker · 049180 ISIN · KR7049180003 KO Manufacturing
Open in API
Filings indexed 396 across all filing types
Latest filing 2019-12-31 Capital/Financing Update
Country KR South Korea
Listing KO 049180

About CELLUMED CO., LTD.

http://www.clnzyme.co.kr/

CELLUMED CO., LTD. is a biotechnology company specializing in the development and manufacturing of medical devices, tissue grafts, and advanced biologics. The company operates as a human tissue bank, producing and supplying a variety of bone graft materials, including allografts and xenografts, for transplantation. Its medical device portfolio features orthopedic implants, with a key product being an artificial knee joint system. In the biologics sector, Cellumed develops growth factors and provides specialized enzymes, such as CLnZyme, which are utilized in the research, development, and production of RNA-based vaccines and therapeutics.

Recent filings

Filing Released Lang Actions
단일판매ㆍ공급계약체결
Capital/Financing Update Classification · 1% confidence The document is a formal regulatory disclosure from a Korean company (Cellumed) regarding a 'Single Sale/Supply Contract' (단일판매ㆍ공급계약체결). It details the contract value, counterparty, and duration. Since this is a specific regulatory disclosure of a material business event that does not fit into the other specialized categories like M&A, dividends, or financial reports, it falls under the general regulatory filing category.
2019-12-31 Korean
기타시장안내(상장적격성 실질심사 대상 결정 )
Regulatory Filings Classification · 1% confidence The document is a formal announcement from the Korea Exchange (KRX) regarding the company Cellumed. It notifies the market that the company has been placed under review for potential delisting (상장적격성 실질심사 대상 결정). This is a regulatory announcement concerning the company's listing status on the exchange, which fits the 'Regulatory Filings' (RNS) category as it is a specific market notice regarding regulatory compliance and listing status.
2019-12-26 Korean
주권매매거래정지기간변경(상장적격성 실질심사 대상 결정)
Delisting Announcement Classification · 1% confidence The document is a short regulatory notice regarding the suspension of trading for (주)셀루메드 due to a review of listing eligibility. It does not fit into specific categories like financial reports, dividends, or director dealings. As it is a regulatory announcement regarding trading status, it falls under the RNS (Regulatory Filings) category.
2019-12-26 Korean
주요사항보고서(타법인주식및출자증권양수결정)
Share Issue/Capital Change Classification · 1% confidence The document is a 'Major Matter Report' (주요사항보고서) filed with the Korea Exchange (KRX) regarding the acquisition of shares in another company (타법인 주식 및 출자증권 양수결정). This is a specific regulatory disclosure required for material corporate events such as M&A or significant investments. Since it does not fit into the specific categories of M&A (which usually refers to full takeovers or mergers) or other specialized categories, it falls under the general regulatory filing category for material corporate disclosures.
2019-12-17 Korean
주주명부폐쇄기간또는기준일설정
Regulatory Filings Classification · 1% confidence The document is a short regulatory announcement regarding the suspension of share registration (shareholder register closure) for the purpose of determining shareholders for an upcoming Annual General Meeting. It does not contain the full report or meeting materials, but rather serves as a formal regulatory notice of a corporate action. Given it is a standard regulatory announcement that does not fit into specific categories like dividend or share issuance, it is classified as a general regulatory filing.
2019-12-12 Korean
벌금등의부과
Regulatory Filings Classification · 1% confidence The document is a regulatory disclosure from Cellumed regarding the imposition of a fine (penalty) by the Securities and Futures Commission due to accounting violations. This type of disclosure regarding regulatory penalties, legal sanctions, or administrative fines falls under the category of Legal Proceedings Report (LTR) as it details a regulatory action and the company's response.
2019-12-10 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.